Boston Pharmaceuticals has appointed Ian Sanderson as chief financial officer. As a member of Boston Pharmaceuticals’ senior leadership team, Mr. Sanderson will be involved with the company’s evaluation, acquisition, and development of differentiated clinical programs for the Boston Pharmaceuticals drug portfolio. Robert Armstrong, chief executive officer and co-founder of Boston Pharmaceuticals said, “Ian has extensive expertise in the evaluation and financing of clinical development program...